Takeda Pharmaceutical Co Ltd. said it would suspend use of 1.63 million doses of Moderna Inc.’s Covid-19 vaccine in Japan after it received reports of foreign particles in the vials from several vaccination sites.
Takeda Pharmaceutical Co Ltd. said it would suspend use of 1.63 million doses of Moderna Inc.’s Covid-19 vaccine in Japan after it received reports of foreign particles in the vials from several vaccination sites.